Jacobson Tyler A, Bae Yeunook, Kler Jasdeep S, Iyer Ramsunder, Zhang Runze, Montgomery Nathan D, Nunes Denise, Pleil Joachim D, Funk William E
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States.
University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
Environ Sci Technol. 2024 Feb 27;58(8):3580-3594. doi: 10.1021/acs.est.3c04981. Epub 2024 Feb 14.
Mycotoxins are a heterogeneous group of toxins produced by fungi that can grow in staple crops (e.g., maize, cereals), resulting in health risks due to widespread exposure from human consumption and inhalation. Dried blood spot (DBS), dried serum spot (DSS), and volumetric tip microsampling (VTS) assays were developed and validated for several important mycotoxins. This review summarizes studies that have developed these assays to monitor mycotoxin exposures in human biological samples and highlights future directions to facilitate minimally invasive sampling techniques as global public health tools. A systematic search of PubMed (MEDLINE), Embase (Elsevier), and CINAHL (EBSCO) was conducted. Key assay performance metrics were extracted to provide a critical review of the available methods. This search identified 11 published reports related to measuring mycotoxins (ochratoxins, aflatoxins, and fumonisins) using DBS/DSS and VTS assays. Multimycotoxin assays adapted for DBS/DSS and VTS have undergone sufficient laboratory validation for applications in large-scale population health and human biomonitoring studies. Future work should expand the number of mycotoxins that can be measured in multimycotoxin assays, continue to improve multimycotoxin assay sensitivities of several biomarkers with low detection rates, and validate multimycotoxin assays across diverse populations with varying exposure levels. Validated low-cost and ultrasensitive minimally invasive sampling methods should be deployed in human biomonitoring and public health surveillance studies to guide policy interventions to reduce inequities in global mycotoxin exposures.
霉菌毒素是一类由真菌产生的异质性毒素,这些真菌可在主粮作物(如玉米、谷物)中生长,由于人类通过食用和吸入而广泛接触,从而带来健康风险。针对几种重要的霉菌毒素,已开发并验证了干血斑(DBS)、干血清斑(DSS)和微量移液器定量取样(VTS)检测方法。本综述总结了开发这些检测方法以监测人类生物样本中霉菌毒素暴露情况的研究,并强调了未来的方向,以促进将微创取样技术作为全球公共卫生工具。我们对PubMed(医学期刊数据库)、Embase(爱思唯尔数据库)和CINAHL(EBSCO数据库)进行了系统检索。提取了关键检测性能指标,以对现有方法进行批判性综述。该检索确定了11篇已发表的报告,这些报告涉及使用DBS/DSS和VTS检测方法测量霉菌毒素(赭曲霉毒素、黄曲霉毒素和伏马菌素)。适用于DBS/DSS和VTS的多霉菌毒素检测方法已在实验室进行了充分验证,可用于大规模人群健康和人类生物监测研究。未来的工作应扩大多霉菌毒素检测方法中可测量的霉菌毒素数量,继续提高几种低检出率生物标志物的多霉菌毒素检测灵敏度,并在不同暴露水平的不同人群中验证多霉菌毒素检测方法。应在人类生物监测和公共卫生监测研究中采用经过验证的低成本、超灵敏微创取样方法,以指导政策干预,减少全球霉菌毒素暴露方面的不平等现象。